Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 1998

View Archived Issues

Company Profile: OSI Pharmaceuticals

Novo Nordisk and Aradigm to develop pulmonary insulin delivery system

Company Profile: Adolor

Pfizer discloses indazole inhibitors of PDE and TNF production

Encouraging results reported for Cel-Sci's Multikine

Vapreotide, RC-3940-II and cetrorelix: novel peptide analogues for treating renal cell carcinoma

Excellent phase III results reported for bropirimine in CIS

Eisai trims its product pipeline

JTT-501, a novel treatment for NIDDM

tgAAV-CFTR research results published in The Lancet

New antiallergic and antiinflammatory compounds developed by Astra researchers

Novel rapamycin derivatives patented by AHP

Warner-Lambert team describes preferential inhibitors of MMP-2 and MMP-3

Pfizer team reveals heterobicyclic CRF antagonists

Neuroprotective agents based on enzyme inhibition prepared at P&U

BMS/IRORI strategic alliance to develop ultra-high-throughput combinatorial chemistry system

Duke University pioneers novel therapy for GBM

Astra stops development of local anesthetic

More on Ilex Oncology's chemopreventive agent

First European clearance for Eisai's Pariet

Combination immunotherapy of renal cell carcinoma: efficacy established in phase II trial

Maxamine plus IFN-alpha appears effective and safe in nonresponding HCV patients

Alexion C5 inhibitor provides protection from damage in animal heart attack model

SSRIs versus tricyclics as regards risk of hip fracture in the elderly

Mechanism of neuroprotective effect of selegiline; efficacy in HIV-associated dementia

ET antagonist protects against ciclosporin-induced nephrotoxicity in rats

NexMed begins clinical trials of female sexual dysfunction product

CNI-H0294, an anti-HIV agent with a unique mechanism of action

French regulatory approval obtained for AmBisome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...